1Chitturi S,Wong VW,Farrell G. Nonalcoholic fatty liver in Asia:Firmly entrenched and rapidly gaining ground[J].{H}Journal of Gastroenterology and Hepatology,2011,(Suppl 1):163-172.
2Wong VW,Wong GL,Choi PC. Disease progression of nonalcoholic fatty liver disease:a prospective study with paired liver biopsies at 3 years[J].{H}GUT,2010.969-974.
3Ascha MS,Hanouneh IA,Lopez R. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis[J].{H}HEPATOLOGY,2010.1972-1978.
4Rafiq N,Bai C,Fang Y. Long-term follow-up of patients with nonalcoholic fatty liver[J].{H}Clinical Gastroenterology and Hepatology,2009.234-238.
5Wong VW,Wong GL,Yip GW. Coronary artery disease and cardiovascular outcomes in patients with nonalcoholic fatty liver disease[J].{H}GUT,2011.1721-1727.
8Puri P,Wiest MM,Cheung O. The plasma lipidomic signature of nonalcoholic steatohepatitis[J].{H}HEPATOLOGY,2009.1827-1838.
9Puri P,Baillie RA,Wiest MM. A lipidomic analysis of nonalcoholic fatty liver disease[J].{H}HEPATOLOGY,2007.1081-1090.
10Gorden DL,Ivanova PT,Myers DS. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease;comparison to a murine model[J].PLoS One,2011.e22775.
3Cuvillier O. Sphingosine in apoptosis signaling. Biochim Biophys Acta, 2002, 1585(2/3): 153-162.
4Baumruker T, Bomancin F, Billich A. The role of sphingosine and eeramide kinases in inflammatory responses. Immunol Lett, 2005, 96(2): 175-185.
5Di P G, Di C P. Phosphoinositides in cell regulation and membrane dynamics. Nature, 2006, 443(7112): 651-657.
6Meyer zu Heringdorf D, Jakobs K H. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta, 2007, 1768(4): 923-940.
7Brinkrnann V. Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther, 2007, 115(1): 84-105.
8Morales A, Lee H, Goni F M, et al. Sphingolipids and cell death. Apoptosis, 2007, 12(5): 923-939.
9van Meer G. Cellular lipidomics. EMBO J, 2005, 24 (18): 3159-3165.
10Hart X L, Gross R W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res, 2003, 44 (6):1071-1079.
